Delivery Order SPE2DE22D0008-SPE2D625F9BU6
Award Date 7/29/25
Potential Completion Date 8/1/25
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60607, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Alba Bioscience, Inc. was awarded a delivery order contract by the Defense Logistics Agency's Medical Supply Chain division on August 14, 2025, for the supply of ALBACLONE Anti-D Blend, a specialized blood bank reagent used in immunohematology testing. This firm fixed-price contract carries a ceiling value of $1,464.00 with an ultimate completion date of August 19, 2025. The contract was awarded on a non-competitive basis with no set-aside designation, reflecting Alba Bioscience's established...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a delivery order contract to Alba Bioscience, Inc. for ALBACLONE anti-FYB antibody screening products. The contract, valued at $12,875 with a firm fixed price structure, was executed on September 4, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside award represents a continuation of Alba Bioscience's established role as a critical supplier of specialized in vitro diagnostic...
- Alba Bioscience, Inc. was awarded a delivery order valued at $6,270 on September 4, 2025, for the ALBACYTE Antibody ID Panel (10-Cell) under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain division. The contract is scheduled for completion by November 7, 2025, and will be performed at the contractor's facility in Chicago, Illinois. This non-set-aside award represents Alba Bioscience's continued role as a critical supplier of specialized in vitro diagnostic...
- Alba Bioscience, Inc., a Chicago-based supplier of in vitro diagnostics and blood bank reagents, was awarded a delivery order for ALBACYTE Antibody ID Panel (10-Cell) on June 2, 2025, with a ceiling value of $12,895. The contract is a firm fixed price delivery order with an ultimate completion date of August 6, 2025, and was issued without a set-aside designation, indicating competitive procurement. The award was funded by the Defense Logistics Agency's Medical Supply Chain division,...
- The Defense Logistics Agency, operating under the Defense or Civilian designation, awarded a delivery order contract (4568409675) to Alba Bioscience, Inc. on June 2, 2025, for the supply of ALBACLONE Anti-K antibodies. The contract represents a firm fixed price delivery order with a ceiling value of $15,944.00 and an ultimate completion date of June 5, 2025. The award was made on a non-set-aside basis, reflecting Alba Bioscience's competitive standing as an established supplier of specialized...
- This is a federal contract award to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various U.S. government agencies. The contract, valued at $4,886.95, is a delivery order issued by the Defense Logistics Agency Troop Support Medical for the supply of ALBACLONE Anti-S (Big S) blood bank products. The contract has a firm fixed-price pricing type and...
- This is a federal contract award to Alba Bioscience, Inc., a for-profit organization based in Chicago, Illinois, that specializes in the production and distribution of in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials for federal healthcare systems. The contract, worth $1,118.00, is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is July 22, 2025. The contract is funded by the Defense Logistics Agency (DLA),...
- This federal contract award is for the delivery of ALBACYTE antibody screening (3-cell) products to the Defense Logistics Agency (DLA). The contract, valued at $1,281.00, was awarded to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, and other biomedical products to various federal agencies, including the Department of Veterans Affairs (VA) and the Department of Health and Human Services (HHS). The...
- This is a federal contract award to Alba Bioscience, Inc., a for-profit organization specializing in in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials. The contract is a Delivery Order worth $4,740.00 for ALBACLONE Anti-A products, awarded by the Defense Logistics Agency (DLA), which supports the Department of Defense and other federal healthcare systems. The contract has a firm fixed-price pricing type and an ultimate completion date of July...
- This federal contract award to Alba Bioscience, Inc., a foreign-owned for-profit organization, is for the delivery of ALBACLONE Anti-A blood typing reagents to the Defense Logistics Agency (DLA) Troop Support Medical. The $3,555.00 firm-fixed-price contract has a period of performance through June 13, 2024 and was awarded on June 10, 2024. Alba Bioscience, a subsidiary of Quotient Biodiagnostics, Inc., is a leading supplier of specialized blood banking products and services to federal...